Want to join the conversation?
$NP said that at the end of 1Q16, debt was $239MM and debt-to-EBITDA ratio was around 1.5 with over $100MM of borrowing capacity available on existing credit facilities. The company's effective tax rate was 33% vs. 37% reported in 1Q15. The lower rate is largely due to differences in timing of R&D credits recognized all at once in 4Q15.
Keep your eyes on $FLXN. This one could ascend rapidly. Great time to buy your favourite bio stocks. Make more $$$
$CRM on the pop today.. big bubble.
Slumping and down the drain... $HDSN. Flush out your holdings !
$KITE I am loving this one... really flying like a kite today :-)